From info at patacky.com Wed Aug 3 22:46:01 2005 From: info at patacky.com (info@patacky.com) Date: Thu Aug 4 01:01:57 2005 Subject: [Authors] $BCK@-%G%j%X%k!JI{6H!&@l6H!KEPO?40A4L5(B Message-ID: <20050804024601.26229.qmail@mail.patacky.com> $B"#(B-$B%k%C%/%9<+K}(B-$B"#(B-$B6ZFy<+K}(B-$B"#(B-$BM%$7$5<+K}(B-$B"#(B-$B%F%/%K%C%/<+K}!]"#(B $B!ZCk%3!<%9!["-(B http://www.00-love1.com/?deli1 $B!ZCK@-=PD%%G%j%X%k%9%?%C%UJg=8Cf!*!*![(B $B"(C;4|!&D94|$I$A$i$G$b#O#K!"B`2q$O2?;~$G$b<+M3$K=PMh$^$9!":FEPO?#O#K!*!*(B $B"(CK@-=PD%%G%j%X%k$r5a$a$F$$$k=w@-B??tEPO?!*!*(B $B"(0l2s(B2$B;~4VDx$N$*IU$-9g$$$G<}F~(BUp$B!*!*(B $B!ZLk%3!<%9![(B http://www.00-love1.com/?deli2 $B"#"#"#"#"#"#"#"#"#"#"#"#"#"#(B The reception refusal of mail $B:#8e!"l9g$O2<5-$^$G$4O"Mm2<$5$$!#(B sweet_777@pochta.ru $B"#"#"#"#"#"#"#"#"#"#"#"#"#"#(B $B"((B18$B:PL$K~$N$4MxMQ$O=PMh$^$;$s(B From norman at 1-choice.com Sat Aug 6 02:20:52 2005 From: norman at 1-choice.com (Alec White) Date: Sat Aug 6 02:08:23 2005 Subject: [Authors] Rolex watches starting under $199.99 Message-ID: <2f0201c59a4e$b64bbe66$c1b8664d@1-choice.com> Skipped content of type multipart/alternative From info at dfkgj.com Sat Aug 6 15:29:32 2005 From: info at dfkgj.com (info@dfkgj.com) Date: Sat Aug 6 17:43:13 2005 Subject: [Authors] $B40A4L5NA$NAG?M=PD%%[%9%H$N%"%k%P%$%H(B Message-ID: <20050806192932.3151.qmail@mail.dfkgj.com> $B(.(,(/(.(,(/(.(,(/(.(,(/(B $B(-AG(-(-?M(-(-=P(-(-D%(-(B $B(1(,(0(1(,(0(1(,(0(1(,(0(B http://www.ecdrf.com/?freehost $B"(%[%9%HBgJg=8!J$*;n$740A4L5NAEPO?#O#K!*!K(B $B"($9$Y$F%(%C%AL\E*$@$+$iNI$$;W$$$r$7$F>.8/$$2T$.!*(B $B"($*Ajn!&#S>n!&#M>n!&(B $B%J!<%9!&%9%C%A!<$J$I(B $B(.(,(/(.(,(/(.(,(/(.(,(/(B $B(-40(-(-A4(-(-L5(-(-NA(-(B $B(1(,(0(1(,(0(1(,(0(1(,(0(B http://www.ecdrf.com/?freehost $B(.(,(/(.(,(/(B $B(-$*;n$7#O#K(-(B $B(1(,(0(1(,(0(B $B"(;E;v$N9g4V!"5YF|$rMxMQ$7$F<}F~%"%C%W$r$7$^$;$s$+!*D64JC1$JI{6H$G$9!#(B $B!y5.J}$b%j%C%A$K$J$j$^$;$s$+!)(B http://www.ecdrf.com/?freehost $B!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a(B An unnecessary person please reply at the following. $B:#8e!"l9g$OJV?.2<$5$$!#(B a245_goawg@poppymail.com $B!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a!&!a(B 18$B:PL$K~$OMxMQ6X;_$G$9!#(B From cgenerali at cutter.com Wed Aug 10 14:06:31 2005 From: cgenerali at cutter.com (Cutter IT Journal) Date: Wed Aug 10 13:29:10 2005 Subject: [Authors] Call for Papers: IT-related Litigation Message-ID: <416-2200583101863141@zoej> CALL FOR PAPERS Cutter IT Journal Ed Yourdon, Guest Editor Abstract Submission Date: 22 August 2005 Articles Due: 30 September 2005 IT-related Litigation: Likely Trends and Recommended Practices There are at least three major trends that continue to generate a large number of expensive and painful IT-related lawsuits. First, even though many IT organizations have improved their project management and software development processes, there are still numerous instances of large, expensive projects that are substantially behind schedule and/or over budget -- or, even worse, cancelled before completion or rejected by dissatisfied clients. Second, the ever-increasing outsourcing trend means that system development efforts increasingly involve “arms-length” relationships between vendors and suppliers, rather than the traditional approach of an internal IT organization developing a system for end users and business departments that it generally understood reasonably well. In the new scenario, it’s far less likely that the vendor and client have any significant previous experience working together, and they often represent very different corporate cultures. Third, an ever greater number of the products and services offered by companies all over the world involve intellectual property (IP) that is either embedded in software or firmware, stored in corporate databases, or embodied in business processes that can be protected by patents, copyrights, or trade secret mechanisms. As a result, companies have more and more opportunities to sue, or to be sued, if competitors in the same industry happen to be using similar (or identical) software, firmware, databases, or business processes. And as if this area wasn’t already complex enough, the complexity is compounded by the presence of open software -- which may have found its way into the software products that a company thought it could protect as its own IP. Because of these trends, it’s more important than ever for IT organizations to formulate a proactive strategy to protect their IP and to ensure that their outsourcing contracts won’t degenerate into a litigious confrontation. Some of this involves careful crafting of contracts and legal documents, but it also requires litigation-savvy practices and procedures on the part of senior management, project management, and IT professionals at every level in the organization. The November 2005 Cutter IT Journal issue will explore the litigation-related trends we are likely to face over the next several years and strategies that have proven successful for dealing with litigation both before and after a lawsuit is filed. TOPICS OF INTEREST MAY INCLUDE (but are certainly not limited to) any combination of the following: * What are the likely trends for different types of IT-related litigation? Should we expect to see more, or fewer, lawsuits in the future? What business issues and practices are likely to generate new forms of lawsuits in the future (e.g., data security problems that could create class-action lawsuits by corporate customers whose credit card numbers have been stolen)? * What does senior management -- e.g., the CXOs and the Board of Directors -- need to know about the organization’s exposure and risk associated with IT-related litigation? What are the opportunities (e.g., launching lawsuits to protect its software patents and IP) that it should explore? * What processes and practices can an IT organization use to anticipate and prevent a hostile lawsuit for IP infringement? For example, what new practices exist in the area of “clean-room” development that can help ensure that a development team has not been “tainted” by exposure to another firm’s protected IP? * Are there new techniques in IT-related “forensic” work to determine whether program A was copied from, or derived from, program B? How can this be explained to a typical non-technical jury? * Since many IT-related project failures can be traced back to poorly written contracts between vendors and clients (with poorly described requirements and expectations, poorly described acceptance testing processes, etc.), what can be done to motivate IT project managers in both the client and vendor organizations to pay more attention to this area? Historically, the commonsense advice in this area has been ignored by many project managers because they know they will have moved on to another job long before the project finishes (or fails) -- and thus long before any litigation occurs. Even worse, it never occurs to them that litigation could occur. What can be done to solve this problem? * What kind of evidence and documentation should a vendor organization and/or a client organization accumulate during a system development project in order to substantiate their claims in a lawsuit, which may not reach trial until several years after the project has finished? TO SUBMIT AN ARTICLE IDEA Please respond to Ed Yourdon, ed@yourdon.com, with a copy to itjournal@cutter.com, by 22 August 2005 and include an extended abstract and an article outline. ARTICLE DEADLINE Articles are due on 30 September 2005. EDITORIAL GUIDELINES Most Cutter IT Journal articles are approximately 2,500-3,500 words long, plus whatever graphics are appropriate. If you have any other questions, please do not hesitate to contact CITJ’s managing editor Karen Pasley (kpasley@cutter.com) or the Guest Editor, Ed Yourdon (ed@yourdon.com). Editorial guidelines are available at http://www.cutter.com/itjournal/edguide.html AUDIENCE Typical readers of Cutter IT Journal range from CIOs and vice presidents of software organizations to IT managers, directors, project leaders, and very senior technical staff. Most work in fairly large organizations: Fortune 500 IT shops, large computer vendors (IBM, HP, etc.), and government agencies. 48% of our readership is outside of the US (15% from Canada, 14% Europe, 5% Australia/NZ, 14% elsewhere). Please avoid introductory-level, tutorial coverage of a topic. Assume you're writing for someone who has been in the industry for 10 to 20 years, is very busy, and very impatient. Assume he or she will be asking, "What's the point? What do I do with this information?" Apply the "So what?" test to everything you write. PROMOTIONAL OPPORTUNITIES We are pleased to offer Journal authors a year's complimentary subscription and 10 copies of the issue in which they are published. In addition, we occasionally pull excerpts, along with the author's bio, to include in our weekly Cutter Edge e-mail bulletin, which reaches another 8,000 readers. We'd also be pleased to quote you, or passages from your article, in Cutter press releases. If you plan to be speaking at industry conferences, we can arrange to make copies of your article or the entire issue available for attendees of those speaking engagements -- furthering your own promotional efforts. ABOUT CUTTER IT JOURNAL No other journal brings together so many cutting-edge thinkers, and lets them speak so bluntly and frankly. We strive to maintain the Journal's reputation as the "Harvard Business Review of IT." Our goal is to present well-grounded opinion (based on real, accountable experiences), research, and animated debate about each topic the Journal explores. FEEL FREE TO FORWARD THIS CALL FOR PAPERS TO ANYONE WHO MIGHT HAVE AN APPROPRIATE SUBMISSION.  From 292tajen at absorb.com Tue Aug 16 16:38:36 2005 From: 292tajen at absorb.com (Cuddie Simon) Date: Tue Aug 16 17:45:41 2005 Subject: [Authors] Windows XP Professional + Office XP Professional. For FREE! LIMITED Message-ID: <5d6001c5a2a2$586f8763$a0c3cfaf@absorb.com> WARNING: This e-mail has been altered by MIMEDefang. Following this paragraph are indications of the actual changes made. For more information about your site's MIMEDefang policy, contact MIMEDefang Administrator's . For more information about MIMEDefang, see: http://www.roaringpenguin.com/mimedefang/enduser.php3 An attachment named m.exe was removed from this document as it constituted a security hazard. If you require this document, please contact the sender and arrange an alternate means of receiving it. -------------- next part -------------- Skipped content of type multipart/related From closed at lissamail.com Tue Aug 23 00:22:09 2005 From: closed at lissamail.com (Doctor) Date: Tue Aug 23 01:16:14 2005 Subject: [Authors] Pharmaceutical Revolution Message-ID: <6260724561.20050823002209@lissamail.com> Vlajgra $3.3 Leviytra $3.3 Ciailis $3.7 Imithrex $16.4 Flomuax $2.2 Ultrwam $0.78 Viomxx $4.75 Ambqien $2.2 Valhium $0.97 Xanazx $1.09 Sogma $3 Merizdia $2.2 our site http://congrategnant.com/?GFSMKDUEdHXFpDQXNbRVRcHlZcXhxcRlI= ___ Best regards, Online Pharmaceuticals From combine at precisionhardscape.com Tue Aug 23 00:58:44 2005 From: combine at precisionhardscape.com (Peg) Date: Tue Aug 23 01:29:08 2005 Subject: [Authors] New Breed Equity Reports Message-ID: <75996125734.7510910353@201-255-162-171.mrse.com.ar> ***BREAKING NEWS ALERT ISSUED FOR TUESDAY AUG 23rd*** WORLDWIDE BIOTECH & PHARMACEUTICAL CO MAKES MAJOR MOVE ON MONDAY !!!! CLIMBING AMAZING up+ $2.50 (45.45%) Symbol: WWBP.OB Price: $8.00 Thursday's Target: $12-17 or more. ***You may not be aware of WWBP, but you should be, because this company represents a terrific profit opportunity for early investors. Worldwide Biotech and Pharmaceutical Company, a biotech company, engages in the development, manufacture, and marketing of diagnostic reagents. These diagnostic reagents include hepatitis C viruses, medicines, vaccines, and gene carriers. The company is based in Sarasota, Florida. THIS IS AN ONLINE INTERNET IPO. IF YOU ARE RECEIVING THIS EMAIL, YOU ARE AMONG THE FIRST PUBLIC INVESTORS TO KNOW ABOUT WWBP !!!! A $1,000 dollar investment could yield a $5,000 dollar profit in just ONE trade if you trade out at the top. WWBP should be one of the most profitable stocks to trade this year. It is only a matter of time before it is released out into the investment community and they take it to the moon.. $ GET IN NOW!!! You know the old saying, buy the rumor and sell on the news. Once the news is out it is time to get ready for next rally... JUST DO YOURSELF A FAVOR AND WATCH WWBP again TUESDAY MORNING, and DON'T SAY WE DIDN'T TELL YOU... ****Make no mistake: Our mission at Hot-Stocks-Investors is to claw our way through the thousands of underperforming companies out there to find the golden needle in the haystack the micro-cap DIAMOND that can make you rich. More often than not, the stocks we profile show a significant increase in stock price as you can see with new IPO of WWBP. Sometimes this happens imediately like we saw Mon Aug 22. WE SEE BIG THINGS HAPPENING EVERYDAY, SO WE SAY KEEP YOUR EYE ON WWBP TUESDAY AND WATCH FOR A BIG MOVEMENT AGAIN !!!!!! Disclaimer: Information within this email contains "forwardlooking statements" within the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements". "Forward looking statements" are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands" or that by statements indicating certain actions "may", "could", or "might" occur. Risk factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors overwhich the company has little or no control. The publisher of this newsletter does not represent that the information contained in this message states all material facts or does not omit a material fact necessary to make the statements therein not misleading. All information provided within this email pertaining to investing, ST0CKs, securities must be understood as information provided and not investment advice. The publisher of this newsletter advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in ST0CKs featured within this email. None of the material within this report shall be construed as any kind of investment advice or solicitation. Many of these companies are on the verge of bankruptcy. You can lose all your money by investing in this ST0CK. We urge you to read the company's SEC filings now, before you invest. The publisher of this newsletter is not a registered invstment advisor. Subscribers should not view information herein as legal, tax, accounting or investment advice. In compliance with the SecuritiesAct of 1933, Section 17(b), The publisher of this newsletter is contracted to receive six hundred thousand free trading shares from a third party, not an officer, director or affiliate shareholder for the circulation of this report. Be aware of an inherent conflict of interest resulting from such compensation due to the fact that this is a paid advertisement and is not without bias. The party that paid us has a position in the ST0CK they will sell at anytime without notice. This could have a negative impact on the price of the ST0CK, causing you to lose money. All factual information in this report was gathered from public sources, including but not limited to SEC filings, Company Websites and Company Press Releases. The publisher of this newsletter believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. From eli at ranmamail.com Wed Aug 24 15:24:17 2005 From: eli at ranmamail.com (Doctor) Date: Wed Aug 24 15:13:48 2005 Subject: [Authors] Pharmaceutical revolution In-Reply-To: References: Message-ID: Vlapgra $3.3 Leviktra $3.3 Ciawlis $3.7 Imiterex $16.4 Flomvax $2.2 Ultrham $0.78 Violxx $4.75 Ambdien $2.2 Valqium $0.97 Xanaex $1.09 Sovma $3 Meriwdia $2.2 our site http://brefasatake.com/?GFSMKDUEdHXFpDQXNbRVRcHlZcXhxcRlI= ___ Best regards, Online Pharmaceuticals From dundas at garzagarcia.com Thu Aug 25 13:45:19 2005 From: dundas at garzagarcia.com (Doctor) Date: Thu Aug 25 14:38:43 2005 Subject: [Authors] Pharmaceutical Revolution Message-ID: <6473366975.20050825134519@garzagarcia.com> Vlajgra $3.3 Leviytra $3.3 Ciaslis $3.7 Imitjrex $16.4 Flompax $2.2 Ultrmam $0.78 Vioqxx $4.75 Ambmien $2.2 Valkium $0.97 Xanamx $1.09 Soama $3 Mericdia $2.2 our site http://brefasatake.com/?GFSMKDUEdHXFpDQXNbRVRcHlZcXhxcRlI= ___ Best regards, Online Pharmaceuticals From pmonday at aaronkwok.net Sun Aug 28 00:56:41 2005 From: pmonday at aaronkwok.net (Doctor) Date: Sun Aug 28 01:50:51 2005 Subject: [Authors] Pharmaceutical Revolution Message-ID: <2314979782.20050828005641@aaronkwok.net> Vlasgra $3.3 Leviptra $3.3 Ciahlis $3.7 Imitgrex $16.4 Flomgax $2.2 Ultraam $0.78 Viozxx $4.75 Ambpien $2.2 Valrium $0.97 Xanatx $1.09 Sotma $3 Merirdia $2.2 our site http://oplegazin.com/?GFSMKDUEdHXFpDQXNbRVRcHlZcXhxcRlI= ___ Best regards, Online Pharmaceuticals From Brouwer at fannclub.com Tue Aug 30 04:31:16 2005 From: Brouwer at fannclub.com (Doctor) Date: Tue Aug 30 05:27:26 2005 Subject: [Authors] Pharmaceutical Revolution Message-ID: <0199977375.20050830043116@fannclub.com> Vlaygra $3.3 Levirtra $3.3 Ciahlis $3.7 Imitfrex $16.4 Flommax $2.2 Ultrwam $0.78 Vioexx $4.75 Ambzien $2.2 Valvium $0.97 Xanakx $1.09 Soema $3 Merigdia $2.2 our site http://sotrepedly.com/?GFSMKDUEdHXFpDQXNbRVRcHlZcXhxcRlI= ___ Best regards, Online Pharmaceuticals From brindled at crosley.net Tue Aug 30 17:44:12 2005 From: brindled at crosley.net (Susan) Date: Tue Aug 30 17:33:25 2005 Subject: [Authors] Have you heard of Rolex Timepieces ? Come on in Message-ID: <4147361070.9661963875@gtn9-d9bb8fe7.pool.mediaWays.net> Rolex Sale http://impudent.q67.net/replica/as/ Success isn't permanent, and failure isn't fatal. If we let things terrify us, life will not be worth living. Men seldom make passes At girls who wear glasses. They think to little who talk to much.